Angiopoietin-Primed Autologous Peripheral Blood Stem Cell

· Seoul National Hospital

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Angiopoietin-Primed Autologous Peripheral Blood Stem Cell, covering 2024-12-03 to 2024-12-03. Get the full timeline:

Most recent: Clinical Trial Update: Therapeutic Use of Angiopoietin-Primed Autologous Peripheral Blood Stem Cell in Myocardial Infarction [Phase 3]

See pricing